Massagué announces developments to prevent metastasis in breast cancer
The researcher Joan Massagué announced they have discovered that breast cancer metastasis by attacking the protein could be avoided SRC, a vital cog in the supply of cancerous cells lethal during years stay dormant in vital organs, before manifesting itself.
Massagué made this announcement after receiving from the hands of the Regional Minister for Health of the Generalitat, Marina Geli, the International Foundation Award Santiago Dexeus Font, who was scheduled to give him the Minister of Science and Innovation, Cristina Garmendia, who by evil time was unable to travel to Barcelona.
Dr. Massagué, who is also the Prince of Asturias Prize in scientific research, is program director of cancer biology and genetics at Memorial Sloan-Kettering Cancer Center in New York and associate director of the Institute of Biomedical Research of Barcelona, and is considered one of the top researchers in the areas of regulation of cell division and cancer metastasis.

The scientist also explained that medicine in the market, which is used to treat chronic myeloid leukemia as the first treatment fails, which acts against the protein SRC, which means that “if this piece is eliminated short supply these latent malignant cells to live. ” Massagué said that because clinical trials are being designed based on this theory and the good thing about this is that there is already a target protein SRC, and, secondly, a drug that is on the market, and now join both to see if they confirm their hopes.
The scientist recalled that metastasis is making it difficult for physicians treating cancer and 90% of the failures is precisely that from the primary tumor is an invasion of distant cells that fail to remove with current treatments and that after years manage to metastatic colonization in vital organs.
In his speech insisted that when starting a cancerous tumor, and before it is diagnosed, there is already cancer cells that travel through the bloodstream to other organs, and that while 99.99% of them die from conditions extreme, a few live and succeed in infiltrating the lungs, liver, brain or kidney, to reappear later.






